This study is testing a new drug, **NKT3964**, for adults with **advanced or metastatic solid tumors**. "Advanced" means the cancer is at a late stage, and "metastatic" means it has spread to other parts of the body. The study has two parts: Dose Escalation and Dose Expansion. In Dose Escalation, researchers find a safe dose by slowly increasing the drug amount given to participants. They also study how the body uses the drug, called pharmacokinetics (PK). In Dose Expansion, they test how well this dose works against the cancer. Participants need to have specific types of cancer and must have tried other treatments first.
**Key Points:**
- **Participation**: Must have specific advanced cancers and tried other treatments.
- **Study Visits**: Requires providing tumor samples and regular check-ups.
- **Risks**: Possible side effects and interactions with other health conditions.
Please consider these points before deciding to participate. Always discuss with your doctor to see if this study is a good fit for you.
How understandable was the trial content above?
Hard to understand
Easy to understand